Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy

Experimental Neurology

Volumn 172, Issue 1, 2001, Pages 211-219

  Obrosova, Irina G ^a   Fathallah, Lamia ^b   Stevens, Martin J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

4 hydroxy alkenals; Ascorbate; Glutathione; Malondialdehyde; Nerve growth factor; Oxidative stress; Rat; Sciatic nerve; Streptozotocin induced diabetes; Taurine

Indexed keywords

ASCORBIC ACID; DEHYDROASCORBIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; MALONALDEHYDE; NERVE GROWTH FACTOR; STREPTOZOCIN; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCIATIC NERVE; SPECTROFLUOROMETRY;

EID: 0035215435     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7789     Document Type: Article

References (94)

1. Estimation of hydroxyl free radical levels in vivo based on liquid chromatography with electrochemical detection
2. Regulation of JNK signaling by GSTp
3. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress
4. The antioxidant action of taurine, hypotaurine and their metabolic precursors
5. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats
6. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat
7. Vitamin C
8. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats
9. 2 and signalling through the p38 pathway in diabetic rats
10. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radical examined using transition metal chelating agents
11. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-dibetic rats
12. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats
13. Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats
14. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids
15. Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats
16. Taurine and myocardial noradrenaline
17. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes
18. Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats
19. Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes: Effects of insulin and aldose reductase inhibition
20. Effects of hypoxia and severity of diabetes on Na,K-ATPase activity and arachidonoyl-containing glycerophospholipid molecular species in nerve from streptozotocin diabetic rats
21. Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals: Mechanistic aspects of the colorimetric assay of lipid peroxidation
22. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy
23. Alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support
24. BCL-2 expression or antloxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells
25. The role of antioxidants in the prevention of t-butyl hydroperoxide-induced chemiluminescence
26. Reactive oxygen species, cell signaling, and cell injury
27. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy
28. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
29. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy
30. Amino acid analysis and enzymatic sequence determination of peptides by an improved o-phthaldialdehyde precolumn labeling procedure
31. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy
32. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; Comparison with essential fatty acids
33. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats
34. Arninoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals
35. Modelling cortical cataractogenesis 22: Is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity?
36. A role for superoxide in protein kinase C activation and induction of long-term potentiation
37. Impact of oxidative stress on signal transduction control by phosphotyrosine phosphatases
38. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices
39. Isolation, expression, and regulation of the pgr1(+) gene encoding glutathione reductase absolutely required for the growth of Schizosaccha romyces pombe
40. L-Deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells
41. Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice
42. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes
43. Nerve function and regeneration in diabetic and galactosemic rats: Antioxidant and metal chelator effects
44. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction: Perfusion, maturation and regeneration following freeze damage in diabetic rats
45. Oxygen free radical effects in sciatic nerve in experimental diabetes
46. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy
47. α-lipoic acid prevents buthionine-sulfoximine-induced cataract formation in newborn rats
48. Nonosmotic diabetic cataracts
49. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons
50. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia
51. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats
52. Aldose reductase inhibitors increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats
53. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats
54. Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy
55. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy
56. Ceramide selectively inhibits apoptosis-associated events in NGF-deprived sympathetic neurons
57. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats
58. Effect of alpha tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve
59. Interaction between osmotic and oxidative stress in diabetic precataractous lens: Studies with a sorbitol dehydrogenase inhibitor
60. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: A prevention study
61. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens
62. Evaluation of an ARI on diabetic nerve function, metabolism and antioxidant status: An intervention study
63. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: An intervention study
64. Antioxidative defense in diabetic peripheral nerve: Effect of DL-α-lipoic acid, aldose reductase inhibitor and sorbitol dehydrogenase inhibitor
65. 1-adrenoceptor antagonist on nerve function, metabolism and antioxidative defense
66. Poly(ADP-ribosyl)ation inhibitors correct conduction deficits and energy metabolism in experimental diabetic neuropathy (EDN)
67. Antioxidants attenuate early upregulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats
68. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor
69. α-lipoic acid as a biological antioxidant
70. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products
71. Depletion of taurine in experimental diabetic neuropathy: Implications for nerve metabolic, vascular and functional deficits
72. Taurine protects the heart from neutrophil-induced reperfusion injury
73. A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats
74. Glycemic control and not protein kinase C inhibition prevents the early decrease of glutathione peroxidase activity in peripheral nerve of diabetic mice
75. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine
76. Biochemical changes in lens, aqueos humor and vitreous body and effects of aldose reductase inhibitor (TAT) on rats with experimental diabetes
77. Effects of oxidative stress on phospholipid signaling in rat cultured astrocytes and brain slices
78. Experimental diabetic neuropathy: An update
79. Downregulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells
80. Effect of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy
81. Endogenous ascorbate regenerates vitamin E in the retina directly and in combination with exogenous dihydrolipoic acid
82. Glycated Cu,Zn-superoxide dismutase in rat lenses: Evidence for the presence of fragmentation in vivo
83. The production of free radicals during the autoxidation of monosaccharides by buffer ions
84. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors
85. Mitogen-activated protein kinases as glucose transducers for diabetic complications
86. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats
87. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
88. Diabetic neuropathy: Pathogenesis and therapy
89. Diabetic neuropathies
90. Pathogenetic mechanisms of diabetic neuropathy: Lessons from animal models
91. Effect of taurine and guanidinoethane sulfonate on glutathione metabolism in the rat
92. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
93. Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of protein-cross-linked free radicals
94. Abnormalities of ascorbic acid metabolism and diabetic control: Differences between diabetic patients and diabetic rats